SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-144124
Filing Date
2015-04-23
Accepted
2015-04-23 16:04:36
Documents
8
Effectiveness Date
2015-04-23

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A d913217ddefa14a.htm DEFA14A 41178
2 GRAPHIC g913217pc_pg01a.jpg GRAPHIC 1358
3 GRAPHIC g913217pc_pg01b.jpg GRAPHIC 6558
4 GRAPHIC g913217pc_pg02a.jpg GRAPHIC 1365
5 GRAPHIC g913217pc_pg02b.jpg GRAPHIC 2281
6 GRAPHIC g913217pc_pg02c.jpg GRAPHIC 2268
7 GRAPHIC g913217pc_pg02d.jpg GRAPHIC 2144
8 GRAPHIC g913217pc_pg03.jpg GRAPHIC 1364
  Complete submission text file 0001193125-15-144124.txt   67101
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 15788480
SIC: 2834 Pharmaceutical Preparations